C52: Malignant neoplasm of vagina
C52 is a billable, specific ICD-10-CM code for malignant neoplasm of vagina. It is valid for submission on a claim.
Check C52 with the rest of the claim: free scrubberExcludes1: never code together
These conditions cannot occur together. Billing both on the same encounter is a denial.
- carcinoma in situ of vagina (D07.2)
Other codes that can never be billed with C52
Their own Excludes1 notes name this code, so the conflict is not listed above.
- C44Other and unspecified malignant neoplasm of skin
Risk adjustment
C52 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 22 Bladder, Colorectal, and Other Cancers0.363 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C52 is named in 58 Medicare coverage policies: 58 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52370Billing and Coding: Bevacizumab and biosimilars
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
Code history
Unchanged in every release from FY2024 to FY2027.